Bosh sahifaAMGN34 • BVMF
add
Amgen
Yopilish kursi
54,36 R$
Kunlik diapazon
54,29 R$ - 55,50 R$
Yillik diapazon
52,10 R$ - 74,33 R$
Bozor kapitalizatsiyasi
149,01 mlrd USD
Oʻrtacha hajm
361,00
Yangiliklarda
AMGN
0,71%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Daromad | 8,15 mlrd | 9,43% |
Joriy xarajat | 3,20 mlrd | 0,47% |
Sof foyda | 1,73 mlrd | 1 630,97% |
Sof foyda marjasi | 21,23 | 1 496,71% |
Har bir ulushga tushum | 4,90 | 23,74% |
EBITDA | 3,52 mlrd | 19,29% |
Amaldagi soliq stavkasi | 12,32% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 8,81 mlrd | -9,25% |
Jami aktivlari | 89,37 mlrd | -3,89% |
Jami passivlari | 83,16 mlrd | -5,45% |
Umumiy kapital | 6,21 mlrd | — |
Tarqatilgan aksiyalar | 537,71 mln | — |
Narxi/balansdagi bahosi | 4,71 | — |
Aktivlardan daromad | 6,46% | — |
Kapitaldan daromad | 8,98% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Sof foyda | 1,73 mlrd | 1 630,97% |
Operatsiyalardan naqd pul | 1,39 mlrd | 101,89% |
Sarmoyadan naqd pul | -447,00 mln | -105,99% |
Moliyadan naqd pul | -4,11 mlrd | -140,46% |
Naqd pulning sof oʻzgarishi | -3,16 mlrd | -155,91% |
Boʻsh pul | 1,21 mlrd | -34,48% |
Haqida
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue.
The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp Wikipedia
Tashkil etilgan
8-apr, 1980
Sayt
Xodimlar soni
28 000